CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | Reed Joshua SVP, Chief Financial Officer | Exercise or conversion | +9,164 | 9,164 | ||
| 2026-10-08 | Reed Joshua SVP, Chief Financial Officer | Shares withheld for taxes | −4,069 | $40.11 | $163K | 5,095 |
| 2026-10-08 | Reed Joshua SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Unit Award | −9,164 | 27,492 | ||
| 2026-03-02 | Reed Joshua SVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +66,430 | 66,430 | ||
| 2026-03-02 | Reed Joshua SVP, Chief Financial Officer | Grant or award · Restricted Stock Unit Award | +30,854 | 30,854 | ||
| 2025-10-08 | Reed Joshua SVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +158,743 | 158,743 | ||
| 2025-10-08 | Reed Joshua SVP, Chief Financial Officer | Grant or award · Restricted Stock Unit Award | +36,656 | 36,656 |
Page 1 of 1 · 7 trades